Novartis

Novartis

Metrics Value

Scope 2 Emissions

2014 = 968,172 tonnes

Disclosure Score

2014 = 94 %

Performance Score

2014 = B /A,A-,B,C,D,E

Indirect greenhouse gas (GHG) emissions (Scope 2) (G4-EN16-a)

2015 = 819,900 tonnes CO2 equivalent

Energy Productivity

2016 = 8.7 %

Greenhouse Gas (GHG) emissions intensity ratio (G4-EN18-a)

2015 = 27 : 1

Reduction of greenhouse gas (GHG) emissions (G4-EN19-a)

2015 = 11,200 tonnes CO2 equivalent

Direct greenhouse gas (GHG) emissions (Scope 1) (G4-EN15-a)

2015 = 530,800 tonnes CO2 equivalent

Greenhouse Gas Productivity

2014 = 38.4 %

Emissions of Ozone-Depleting Substances (ODS) (G4-EN20-a)

2015 = 7 tonnes
+Wikipedia
Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market cap and sales. Novartis manufactures such drugs as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan) and imatinib mesylate (Gleevec/Glivec). Additional agents include ciclosporin (Neoral/Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), and others. In 1996, Ciba-Geigy merged with Sandoz, and the pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity.